Prophylactic administration of melatonin to the mother throughout pregnancy can protect against oxidative cerebral damage in neonatal rats

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 8, 2012, Pages 1254-1259

  Watanabe, Kazushi ^a   Hamada, Fumiaki ^b   Wakatsuki, Akihiko ^a   Nagai, Ryuhei ^b   Shinohara, Koichi ^a   Hayashi, Yoshihiro ^b   Imamura, Rina ^b   Fukaya, Takao ^b  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

ischemia reperfusion; Melatonin; neonatal brain damage; oxidation

Indexed keywords

MELATONIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN DEGENERATION; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; BRAIN PROTECTION; CELL COUNT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; FETUS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; MITOCHONDRIAL RESPIRATION; NEWBORN; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; REPERFUSION INJURY;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CEREBRUM; CHEMOPREVENTION; CYTOPROTECTION; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; FEMALE; MELATONIN; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

EID: 84863872445     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.636094     Document Type: Article

References (52)

1. Little WJ. On the influence of abnormal parturition, difficult labours, premature birth, and asphyxia neonatorum, on the mental and physical condition of the child, especially in relation to deformities. Clin Orthop Relat Res 1966;46:7-22.
2. Blair E, Stanley FJ. Intrapartum asphyxia: a rare cause of cerebral palsy. J Pediatr 1988;112:515-519.
3. Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics 1988;82:240-249.
4. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986;315:81-86. (Pubitemid 16093209)
5. Naeye RL, Peters EC, Bartholomew M, Landis JR. Origins of cerebral palsy. Am J Dis Child 1989;143:1154-1161. (Pubitemid 19246185)
6. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N. Effect of ischemia-reperfusion on xanthine oxidase activity in fetal rat brain capillaries. Am J Obstet Gynecol 1999;181:731-735. (Pubitemid 29453540)
7. Wakatsuki A, Izumiya C, Okatani Y, Sagara Y. Oxidative damage in fetal rat brain induced by ischemia and subsequent reperfusion. Relation to arachidonic acid peroxidation. Biol Neonate 1999;76:84-91. (Pubitemid 29346857)
8. Watanabe K, Wakatsuki A, Shinohara K, Ikenoue N, Yokota K, Fukaya T. Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res 2004;37:276-280. (Pubitemid 39457049)
9. León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005;38:1-9. (Pubitemid 40139304)
10. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007;42:28-42. (Pubitemid 44924323)
11. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007;42:386-393. (Pubitemid 46581663)
12. Hardeland R, Backhaus C, Fadavi A. Reactions of the NO redox forms NO+,*NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 2007;43:382-388. (Pubitemid 47512270)
13. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009;47:109-126.
14. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010;48:297-310.
15. Matuszak Z, Reszka K, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 1997;23:367-372. (Pubitemid 27276772)
16. Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998;25:65-66. (Pubitemid 28319918)
17. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST, Vijayalaxmi, Shepherd AM. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253:614-620. (Pubitemid 29039192)
18. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J 1993;1:57-60.
19. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1-10. (Pubitemid 36140351)
20. Galano A. On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals. Phys Chem Chem Phys 2011;13:7178-7188.
21. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Limson J, Weintraub ST, Qi W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000;29:1177-1185.
22. Zavodnik IB, Lapshina EA, Zavodnik LB, Labieniec M, Bryszewska M, Reiter RJ. Hypochlorous acid-induced oxidative stress in Chinese hamster B14 cells: viability, DNA and protein damage and the protective action of melatonin. Mutat Res 2004;559:39-48. (Pubitemid 38452916)
23. Matuszak Z, Bilska MA, Reszka KJ, Chignell CF, Bilski P. Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem Photobiol 2003;78:449-455.
24. Ximenes VF, Silva SO, Rodrigues MR, Catalani LH, Maghzal GJ, Kettle AJ, Campa A. Superoxide-dependent oxidation of melatonin by myeloperoxidase. J Biol Chem 2005;280:38160-38169. (Pubitemid 43853710)
25. Aydogan S, Yerer MB, Goktas A. Melatonin and nitric oxide. J Endocrinol Invest 2006;29:281-287.
26. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001;34:237-256. (Pubitemid 33615836)
27. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:PL271-PL276. (Pubitemid 24290417)
28. Wakatsuki A, Okatani Y, Shinohara K, Ikenoue N, Kaneda C, Fukaya T. Melatonin protects fetal rat brain against oxidative mitochondrial damage. J Pineal Res 2001;30:22-28. (Pubitemid 32056607)
29. Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 1998;25:129-134. (Pubitemid 28430591)
30. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 1999;26:147-152. (Pubitemid 29183117)
31. Okatani Y, Wakatsuki A, Kaneda C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000;28:89-96. (Pubitemid 30125173)
32. Hamada F, Watanabe K, Wakatsuki A, Nagai R, Shinohara K, Hayashi Y, Imamura R, Fukaya T. Therapeutic effects of maternal melatonin administration on ischemia/reperfusion-induced oxidative cerebral damage in neonatal rats. Neonatology 2010;98:33-40.
33. Fujimaki A, Watanabe K, Mori T, Kimura C, Shinohara K, Wakatsuki A. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta 2011;32:367-372.
34. Nagai R, Watanabe K, Wakatsuki A, Hamada F, Shinohara K, Hayashi Y, Imamura R, Fukaya T. Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta. J Pineal Res 2008;45:271-276.
35. Chance B, Williams GR. A simple and rapid assay of oxidative phosphorylation. Nature 1955;175:1120-1121.
36. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem 1956;17:65-134.
37. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358. (Pubitemid 9194347)
38. Fridovich I. Hypoxia and oxygen toxicity. Adv Neurol 1979;26:255-259.
39. Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996;27:327-31; discussion 332.
40. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-5323.
41. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabó C. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 1997;23:106-116. (Pubitemid 127731745)
42. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabó C. Melatonin is a scavenger of peroxynitrite. Life Sci 1997;60:PL169-PL174. (Pubitemid 27087273)
43. Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997;65:430-442. (Pubitemid 27190697)
44. Bettahi I, Guerrero JM, Reiter RJ, Osuna C. Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase. J Pineal Res 1998;25:34-40.
45. León J, Escames G, Rodríguez MI, López LC, Tapias V, Entrena A, Camacho E, et al. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006;98:2023-2033. (Pubitemid 44298263)
46. Noda Y, Mori A, Liburdy R, Packer L. Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999;27:159-163. (Pubitemid 29487960)
47. Mahal HS, Sharma HS, Mukherjee T. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999;26:557-565. (Pubitemid 29146258)
48. Kotler M, Rodríguez C, Sáinz RM, Antolín I, Menéndez-Peláez A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998;24:83-89. (Pubitemid 28168319)
49. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004;36:1-9. (Pubitemid 38130283)
50. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985;63:29-37.
51. Leviton A, Paneth N. White matter damage in preterm newborns-an epidemiologic perspective. Early Hum Dev 1990;24:1-22. (Pubitemid 20344890)
52. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Semin Neonatol 2001;6:121-133. (Pubitemid 32705983)